Article info

Download PDFPDF
Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy

Authors

  1. Correspondence to Mary Safy-Khan, Rheumatology and Clinical Immunology, UMC Utrecht, 3584 CX Utrecht, The Netherlands; marysafy{at}hotmail.com
View Full Text

Citation

Safy-Khan M, Jacobs JWG, de Hair MJH, et al
Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy

Publication history

  • Received November 19, 2019
  • Revised January 13, 2020
  • Accepted January 16, 2020
  • First published February 7, 2020.
Online issue publication 
March 19, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.